Related references
Note: Only part of the references are listed.Prognostic and predictive markers in pancreatic adenocarcinoma
Nha Le et al.
DIGESTIVE AND LIVER DISEASE (2016)
Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy
Reiko Yamada et al.
PANCREAS (2016)
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
Hyung Soon Park et al.
CANCER RESEARCH AND TREATMENT (2016)
MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions
Yasmin G. Hernandez et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
Wei Han et al.
PLOS ONE (2016)
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae et al.
BRITISH JOURNAL OF CANCER (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
High Levels of Cell-Free Circulating Nucleic Acids in Pancreatic Cancer are Associated With Vascular Encasement, Metastasis and Poor Survival
Nidhi Singh et al.
CANCER INVESTIGATION (2015)
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2015)
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis
Adam E. Frampton et al.
EUROPEAN JOURNAL OF CANCER (2015)
Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer
Y. B. Ma et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis
B. -S. Li et al.
GENETICS AND MOLECULAR RESEARCH (2015)
A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy
Peng Xue et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer
C. Jenkinson et al.
JOURNAL OF PROTEOMICS (2015)
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
Michela Capello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Evaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancer
Amal A. Mohamed et al.
PANCREATOLOGY (2015)
Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis
Si-Biao Su et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Circulating RNAs as new biomarkers for detecting pancreatic cancer
Takahiro Kishikawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: A promising biomarker and therapeutic target for pancreatic cancer
Donglin Liu et al.
ONCOTARGET (2015)
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
Michela Capello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer
Renata D'Alpino Peixoto et al.
CANCER MEDICINE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
Gregory A. Cote et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
Xiaobing Wang et al.
BMC CANCER (2014)
Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian Cancer
Jan Dominik Kuhlmann et al.
CLINICAL CHEMISTRY (2014)
被撤回的出版物: Diagnostic Performance of Serum Macrophage Inhibitory Cytokine-1 in Pancreatic Cancer: A Meta-Analysis and Meta-Regression Analysis (Retracted article. See vol. 34, pg. 742, 2015)
Yan-Zhi Chen et al.
DNA AND CELL BIOLOGY (2014)
Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions
Andrew D. Rhim et al.
GASTROENTEROLOGY (2014)
Diagnostic Significance of Serum Osteopontin Level for Pancreatic Cancer: A Meta-Analysis
Jian-Jun Li et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
William Greenhalf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
MicroRNA-196a and-196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
Emily P. Slater et al.
TRANSLATIONAL ONCOLOGY (2014)
Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
Jin Wang et al.
JOURNAL OF CANCER (2014)
MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens
Tae Ho Hong et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2014)
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S. Caponi et al.
ANNALS OF ONCOLOGY (2013)
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma
David V. Gold et al.
CANCER (2013)
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies
Lorenzo Fuccio et al.
GASTROINTESTINAL ENDOSCOPY (2013)
Long Noncoding RNAs: Past, Present, and Future
Johnny T. Y. Kung et al.
GENETICS (2013)
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma
Alexander Baraniskin et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Analyzing S100A6 Expression in Endoscopic Ultrasonography-guided Fine-needle Aspiration Specimens A Promising Diagnostic Method of Pancreatic Cancer
Guo Zihao et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
Sophie Gourgou-Bourgade et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
PANCREAS (2013)
Aberrant Expression miR-196a Is Associated With Abnormal Apoptosis, Invasion, and Proliferation of Pancreatic Cancer Cells
Minghao Liu et al.
PANCREAS (2013)
Alternative Processing of the U2 Small Nuclear RNA Produces a 19-22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum
Julien Mazieres et al.
PLOS ONE (2013)
Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer
Sukhwinder Kaur et al.
PLOS ONE (2013)
MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm
Yue Xue et al.
CANCER GENETICS (2013)
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Faruk Tas et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Pathology and Molecular Genetics of Pancreatic Neoplasms
Laura D. Wood et al.
CANCER JOURNAL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
Rui Liu et al.
CLINICAL CHEMISTRY (2012)
MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma
Nicolai A. Schultz et al.
MODERN PATHOLOGY (2012)
Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
Alexander Link et al.
PLOS ONE (2012)
Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers
Long Cui et al.
CLINICAL BIOCHEMISTRY (2011)
Serum Biomarker Panels for the Detection of Pancreatic Cancer
Randall E. Brand et al.
CLINICAL CANCER RESEARCH (2011)
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
S. Buenger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
Maria C. Villarroel et al.
MOLECULAR CANCER THERAPEUTICS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers
David T. Ting et al.
SCIENCE (2011)
Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines
Maria Zhivkova-Galunska et al.
CANCER BIOLOGY & THERAPY (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology
Angela Maerten et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
Jipei Liao et al.
MOLECULAR CANCER (2010)
Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma
Ji Kon Ryu et al.
PANCREATOLOGY (2010)
Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
Allen S. Ho et al.
TRANSLATIONAL ONCOLOGY (2010)
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
Hayato Fujita et al.
NEOPLASIA (2010)
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Nils Habbe et al.
CANCER BIOLOGY & THERAPY (2009)
MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
Jin Wang et al.
CANCER PREVENTION RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
Raphael Marechal et al.
CLINICAL CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
Neil Desai et al.
TRANSLATIONAL ONCOLOGY (2009)
Modelling prognostic factors in advanced pancreatic cancer
D. D. Stocken et al.
BRITISH JOURNAL OF CANCER (2008)
Survival and prognostic factors of unresectable pancreatic cancer
Joo Kyung Park et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Mary Dillhoff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
PAW-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma
David V. Gold et al.
CLINICAL CANCER RESEARCH (2007)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
S100A6 is increased in a stepwise manner during pancreatic carcinogenesis:: Clinical value of expression analysis in 98 pancreatic juice samples
Kenoki Ohuchida et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions
Grzegorz Cwik et al.
ARCHIVES OF SURGERY (2006)
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: Relationship to molecular mechanisms of gemcitabine resistance and survival
V Sebastiani et al.
CLINICAL CANCER RESEARCH (2006)
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
E Giovannetti et al.
CANCER RESEARCH (2006)
Serum markers in patients with resectable pancreatic adenocarcinoma: Macrophage inhibitory cytokine 1 versus CA19-9
J Koopmann et al.
CLINICAL CANCER RESEARCH (2006)
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
A Kolb et al.
CANCER BIOLOGY & THERAPY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients
D Vimalachandran et al.
CANCER RESEARCH (2005)
Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes
G Watkins et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance
CS Wang et al.
BRITISH JOURNAL OF CANCER (2004)
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
J Spratlin et al.
CLINICAL CANCER RESEARCH (2004)
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
A Maitra et al.
MODERN PATHOLOGY (2003)
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions
N Sato et al.
ONCOGENE (2003)
Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression
K Yamashita et al.
CANCER (2003)
Identification of novel genes coding for small expressed RNAs
M Lagos-Quintana et al.
SCIENCE (2001)
Share Paper
